Author

Peter M. Wehmeier

Observed names: P M Wehmeier, P. M. Wehmeier, P. Wehmeier, P.M. Wehmeier, Peter M Wehmeier, Peter Matthias Wehmeier, Wehmeier, Peter Matthias

Observed institutions: Philipps University of Marburg, Heidelberg University, Bundesministerium für Forschung, Technologie und Raumfahrt, Central Institute of Mental Health, Eli Lilly (Germany), Medizinische Fakultät Mannheim, Deutsche Forschungsgemeinschaft

OpenAlex ID: A5108798225

Social and Emotional Impairment in Children and Adolescents with ADHD and the Impact on Quality of Life

2010 · Peter M. Wehmeier, Alexander Schacht, et al. · Journal of Adolescent Health · 696

Body image assessment using body size estimation in recent studies on anorexia nervosa. A brief review.

2001 · S. Skrzypek, P. M. Wehmeier, et al. · European Child & Adolescent Psychiatry · 205

Clozapine and Olanzapine Are Associated With Food Craving and Binge Eating

2007 · Michael Kluge, Andreas Schuld, et al. · Journal of Clinical Psychopharmacology · 184

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever

2008 · Michael Kluge, Andreas Schuld, et al. · Psychoneuroendocrinology · 148

Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study

2009 · S. Gebhardt, F. M. Theisen, et al. · Journal of Clinical Pharmacy and Therapeutics · 91

Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs

2005 · Frank M. Theisen, Stefan Gebhardt, et al. · Psychiatric Genetics · 81

Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder

2008 · Mark E. Bangs, Philip Hazell, et al. · PEDIATRICS · 79

Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation

2005 · Peter M. Wehmeier, Stefan Gebhardt, et al. · Psychiatry Research · 71

Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine

2005 · P. M. Wehmeier, P. Heiser, et al. · Journal of Clinical Pharmacy and Therapeutics · 70

PDF

Induced Delusional Disorder

2003 · Peter M. Wehmeier, Nikolaus Barth, et al. · Psychopathology · 55

Olanzapine and clozapine differently affect sleep in patients with schizophrenia: Results from a double-blind, polysomnographic study and review of the literature

2013 · Michael Kluge, Alexander Schacht, et al. · Schizophrenia Research · 49

Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia

2007 · Peter M. Wehmeier, Michael Kluge, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 46

Atomoxetine Versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder: A Double-Blind, Randomized, Multicenter Trial in Germany

2011 · Ralf W. Dittmann, Alexander Schacht, et al. · Journal of Child and Adolescent Psychopharmacology · 45

Long-term patterns of subjective wellbeing in schizophrenia: Cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years

2008 · Martin Lambert, Benno G. Schimmelmann, et al. · Schizophrenia Research · 44

Correlation of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia

2007 · Peter M. Wehmeier, Michael Kluge, et al. · Schizophrenia Research · 42

Effectiveness and Tolerability of Olanzapine in the Treatment of Adolescents with Schizophrenia and Related Psychotic Disorders: Results from a Large, Prospective, Open-Label Study

2008 · Ralf W. Dittmann, Eberhard Meyer, et al. · Journal of Child and Adolescent Psychopharmacology · 41

Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate

2004 · H. Remschmidt, P. Heiser, et al. · European Child & Adolescent Psychiatry · 40

Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS)

2008 · Peter M Wehmeier, Alexander Schacht, et al. · Child and Adolescent Psychiatry and Mental Health · 34

PDF

Psychotherapy with Children and Adolescents

2001 · Peter Matthias Wehmeier, Helen Crimlisk · Cambridge University Press eBooks · 32

Chart Review for Potential Features of Myocarditis, Pericarditis, and Cardiomyopathy in Children and Adolescents Treated with Clozapine

2004 · Peter M. Wehmeier, Mareike Schüler-Springorum, et al. · Journal of Child and Adolescent Psychopharmacology · 31

Effectiveness of Atomoxetine and Quality of Life in Children with Attention-Deficit/Hyperactivity Disorder as Perceived by Patients, Parents, and Physicians in an Open-Label Study

2007 · Peter M. Wehmeier, Ralf W. Dittmann, et al. · Journal of Child and Adolescent Psychopharmacology · 30

Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studies

2009 · Peter M Wehmeier, Ralf W Dittmann, et al. · Child and Adolescent Psychiatry and Mental Health · 26

PDF

Effect of atomoxetine on quality of life and family burden: results from a randomized, placebo-controlled, double-blind study in children and adolescents with ADHD and comorbid oppositional defiant or conduct disorder

2010 · Peter M. Wehmeier, Alexander Schacht, et al. · Quality of Life Research · 25

Pancreatitis Followed by Pericardial Effusion in an Adolescent Treated with Clozapine

2003 · Peter M. Wehmeier, Philip Heiser, et al. · Journal of Clinical Psychopharmacology · 24

Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine

2012 · Michael Kluge, Hubertus Himmerich, et al. · Schizophrenia Research · 22

Works count: 50

Citation count: 2,327

H-index: 24

I10-index: 30